News & Updates

Anxiety, depressive symptoms in JIA tied to pain, stress
Anxiety, depressive symptoms in JIA tied to pain, stress
19 Jan 2022

Moderate to severe symptoms of anxiety and depression have been reported in about one-fourth of children with juvenile idiopathic arthritis (JIA), according to a study. Such symptoms are associated with pain and stress, but not with other disease manifestations.

Anxiety, depressive symptoms in JIA tied to pain, stress
19 Jan 2022
Add-on duloxetine exerts null effect on chronic osteoarthritis pain
Add-on duloxetine exerts null effect on chronic osteoarthritis pain
12 Jan 2022
COVID-19 vaccines safe for patients with rheumatic, musculoskeletal disease
COVID-19 vaccines safe for patients with rheumatic, musculoskeletal disease
11 Jan 2022

Vaccines against SARS-CoV-2 has a safety profile that is similar in patients with inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD) and those with noninflammatory RMD (NI-RMD), according to a study. The vaccines are well tolerated with rare reports of I-RMD flare and serious adverse events.

COVID-19 vaccines safe for patients with rheumatic, musculoskeletal disease
11 Jan 2022
Shorter flare duration best indicator of treatment success in gout
Shorter flare duration best indicator of treatment success in gout
14 Dec 2021

Patients with gout consider flare duration, flare frequency, and pain severity when thinking about treatment efficacy over time, according to a study. Of these factors, shorter flare duration is deemed to be the most common indicator of successful treatment.

Shorter flare duration best indicator of treatment success in gout
14 Dec 2021